«

»

May 04

In patients with renal cell carcinoma.

The identification and advancement of relevant biomarkers is a strategic element of our drug development efforts. We expect to make use of biomarker data out of this scholarly study to inform the future design of rational combos in RCC, along with in additional cancers. This multi-center, single-arm Phase 2 research is designed to assess biomarkers of tivozanib in around 100 sufferers with RCC who experienced a prior nephrectomy at 25 sites in the U.S.‘I think we ought to be careful about artificial cleverness. If I were to guess at what our biggest existential threat is, it’s most likely that,’ said Elon Musk, CEO of electric car maker Tesla Motors. ‘With artificial cleverness, we are summoning the demon. In every those tales with the guy with the pentagram and the holy water, and he’s sure he can control the demon. It generally does not workout.’ Elon Musk is known for the Tesla Motor’s dual-engine Model S sedan, which features a innovative autopilot feature, allowing the automobile to steer itself between lanes.